Prothena moves forward with layoffs; Aldeyra resubmits dry eye drug to FDA

Plus, news about Ventyx Biosciences, Gilead Sciences, Insilico Medicine and Enliven Therapeutics: Prothena lays off 91 workers: The company previously disclosed plans for a "substantial" workforce reduction after it stopped development of ...

Related Posts

Recursion to lay off 20% of staff, a month after slashi...

Jun 10, 2025  0

FDA adcomm votes against new indication for Genentech's...

May 20, 2025  0

Is there still hope for Summit's cancer drug buried in ...

Jun 6, 2025  0

Comments

Name

Email

Comment

Post Comment